Background
In a canine model of premature ventricular contraction-induced cardiomyopathy (PVC-CM), Cav1.2 is downregulated and misplaced from t-tubules. Junctophilin-2 (JPH-2) is also downregulated.
Objective
To understand the role of JPH-2 in PVC-CM, and to probe changes in other proteins involved in dyad structure and function.
Methods
We quantify t-tubule contents (di-8-ANEPPS fluorescence in live myocytes), examine myocyte ultra-structures (electron microscopy), probe JPH-2 interacting proteins (co-immunoprecipitation), quantify dyad and non-dyad protein levels (immunoblotting), and examine subcellular distributions of dyad proteins (immunofluorescence/confocal microscopy). We also test direct JPH-2 modulation of channel function (vs indirect modulation through dyad formation) using heterologous expression.
Results
PVC myocytes have reduced t-tubule contents but otherwise normal ultra-structures. Among nineteen proteins examined, only JPH-2, bridging-integrator-1 (BIN-1) and Cav1.2 are highly downregulated in PVC hearts. However, statistical analysis indicates a general reduction of dyad protein levels when JPH-2 is downregulated. Furthermore, several dyad proteins, including Na/Ca exchanger, are missing or shifted from dyads to peripheral surface in PVC myocytes. JPH-2 directly or indirectly interacts with Cai-handling proteins, Cav1.2 and KCNQ1, although not BIN-1 or other scaffolding proteins tested. Expression in mammalian cells, that do not have dyads, confirms direct JPH-2 modulation of ICaL (Cav1.2/Cavβ2) and IKs (KCNQ1/KCNE1).
Conclusion
JPH-2 is more than a ‘dyad glue’: it can modulate Cai-handling and ion channel function in the dyad region. Downregulation of JPH-2, BIN-1 and Cav1.2 plays a deterministic role in PVC-CM. Dissecting the hierarchical relationship among the three is necessary for the design of therapeutic interventions to prevent the progression of PVC-CM.